Cargando…
Advances of Artificial Intelligence in Anti-Cancer Drug Design: A Review of the Past Decade
Anti-cancer drug design has been acknowledged as a complicated, expensive, time-consuming, and challenging task. How to reduce the research costs and speed up the development process of anti-cancer drug designs has become a challenging and urgent question for the pharmaceutical industry. Computer-ai...
Autores principales: | Wang, Liuying, Song, Yongzhen, Wang, Hesong, Zhang, Xuan, Wang, Meng, He, Jia, Li, Shuang, Zhang, Liuchao, Li, Kang, Cao, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963982/ https://www.ncbi.nlm.nih.gov/pubmed/37259400 http://dx.doi.org/10.3390/ph16020253 |
Ejemplares similares
-
A Novel Acetylation-Immune Subtyping for the Identification of a BET Inhibitor-Sensitive Subgroup in Melanoma
por: Wang, Liuying, et al.
Publicado: (2023) -
Artificial intelligence in dermatology: past, present, and future
por: Li, Cheng-Xu, et al.
Publicado: (2019) -
Artificial intelligence in healthcare: past, present and future
por: Jiang, Fei, et al.
Publicado: (2017) -
Management of Anti-Seizure Medications during Pregnancy: Advancements in The Past Decade
por: Avachat, Charul, et al.
Publicado: (2022) -
Advances in Biodetoxification of Ochratoxin A-A Review of the Past Five Decades
por: Chen, Wenying, et al.
Publicado: (2018)